Notation to File

EVIMIRIS

Alexion Pharmaceuticals, Inc.

Notation to File

NOTE TO THE FILE


SERIAL NUMBER:            88036776

DATE:                                11/08/2018

NAME:                               kmoninghoff

NOTE:         

Searched:                                                             
     Google                            
     Lexis/Nexis                       
     OneLook
     Wikipedia
     Acronym Finder                         Protest evidence reviewed
     Other:

Checked:                                                             
     Geographic significance          
     Surname                          
     Translation
     ID with ID/CLASS mailbox

     Checked list of approved Canadian attorneys and agents

Discussed file with
Attorney/Applicant via:
        phone                           X   Sent email to
        email                               Attorney

     Requested Law Library search           Issued Examiner’s Amendment
     for:                                   and entered changes in TRADEUPS

        PRINT        DO NOT PRINT           Added design code in TRADEUPS
     Description of the mark
     Translation statement                  Re-imaged standard character
                                            drawing
     Negative translation statement             
     Consent of living individual           Contacted TM MADRID ID/CLASS
                                            about misclassified definite ID
     Changed TRADEUPS to:

 X   OTHER:

From: Moninghoff, Kim
Sent: Thursday, November 01, 2018 11:23 AM
To: 'mtepper@teiplaw.com' <mtepper@teiplaw.com>
Cc: 'tmorris@teiplaw.com' <tmorris@teiplaw.com>
Subject: Trademark Application #88036772 UMEZIRIS and three others

 

Mr. Tepper,

 

I’ve been assigned to review the four trademark applications you filed for this applicant:

 

No. 88036772 UMEZIRIS

No. 88036779 UMEBIRIS

No. 88036776 EVIMIRIS

No. 88036782 ADMIZIRIS

 

Before I can approve these applications for publication, the identifications need to be amended to specify the purpose of the goods.  Based on the applicant’s website, I recommend the following:

 

Pharmaceutical preparations for the treatment of hematology, nephrology, neurology, and metabolic disorders, in Class 5.

 

If you consent to this amendment or can provide an acceptable alternative, you can let me know by reply email and I will enter it by Examiner’s Amendment and approve the marks for publication.  If you have any questions, please let me know.

 

If I don’t hear back from you by the end of the day Wednesday (11/7), I will send you formal Office actions with this requirement.  Thank you.

 

Kim Teresa Moninghoff

Trademark Examining Attorney

Law Office 113

Phone:  571-272-4738

Fax: 571-273-4738

 

All informal e-mail communications relevant to this application will be placed in the official application record.

         Sent to TICRS as Serial Number: 88036772
         Sent to TICRS as Serial Number: 88036779

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed